(Q50564697)

English

Developing whole mycobacteria cell vaccines for tuberculosis: Workshop proceedings, Max Planck Institute for Infection Biology, Berlin, Germany, July 9, 2014.

scientific article published on 14 April 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/25882170

Developing whole mycobacteria cell vaccines for tuberculosis: Workshop proceedings, Max Planck Institute for Infection Biology, Berlin, Germany, July 9, 2014. (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/25882170

0 references

1 reference

based on heuristic

inferred from title

author name string

Whole Mycobacteria Cell Vaccines for Tuberculosis Summary Group

1

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/25882170

language of work or name

0 references

publication date

14 April 2015

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/25882170

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/25882170

33

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/25882170

26

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/25882170

3047-3055

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/25882170

Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Prospects for Tuberculosis Elimination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Diagnosis of childhood tuberculosis and host RNA expression in Africa

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Recent advances towards tuberculosis control: vaccines and biomarkers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Recombinant live vaccine candidates against tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

From bacteriology to immunology: the dualism of specificity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Identification of antigens specific to non-tuberculous mycobacteria: the Mce family of proteins as a target of T cell immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

The primary mechanism of attenuation of bacillus Calmette-Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissue

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Tuberculosis: from genome to vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

M. tuberculosis and M. leprae Translocate from the Phagolysosome to the Cytosol in Myeloid Cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Phagosomal rupture by Mycobacterium tuberculosis results in toxicity and host cell death

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Antigen Load Governs the Differential Priming of CD8 T Cells in Response to the Bacille Calmette Guerin Vaccine or Mycobacterium tuberculosis Infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Release of mycobacterial antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guérin mutants that secrete listeriolysin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

The BCG replacement vaccine VPM1002: from drawing board to clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

PEST sequences and regulation by proteolysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

A PEST-like sequence in listeriolysin O essential for Listeria monocytogenes pathogenicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Recombinant BCG ΔureC hly+ induces superior protection over parental BCG by stimulating a balanced combination of type 1 and type 17 cytokine responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

The recombinant tuberculosis vaccine rBCG ΔureC::hly(+) induces apoptotic vesicles for improved priming of CD4(+) and CD8(+) T cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Central memory CD4+ T cells are responsible for the recombinant Bacillus Calmette-Guérin ΔureC::hly vaccine's superior protection against tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Mycobacterium bovis Bacille Calmette-Guérin strains secreting listeriolysin of Listeria monocytogenes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Learning from natural infection for rational tuberculosis vaccine design: from basic science to translational research

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Safety and immunogenicity of the recombinant BCG vaccine VPM1002 in a phase 1 open-label randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

New live mycobacterial vaccines: the Geneva consensus on essential steps towards clinical development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

The second Geneva Consensus: Recommendations for novel live TB vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

PhoP: a missing piece in the intricate puzzle of Mycobacterium tuberculosis virulence

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

ESX-1-induced apoptosis is involved in cell-to-cell spread of Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

The PhoP-dependent ncRNA Mcr7 modulates the TAT secretion system in Mycobacterium tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Protective immunity afforded by attenuated, PhoP-deficient Mycobacterium tuberculosis is associated with sustained generation of CD4+ T-cell memory.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

MVA.85A boosting of BCG and an attenuated, phoP deficient M. tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Safety and Immunogenicity of a Five-Dose Series of Inactivated Mycobacterium vaccae Vaccination for the Prevention of HIV-Associated Tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Immunogenicity of an inactivated mycobacterial vaccine for the prevention of HIV-associated tuberculosis: a randomized, controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Prevention of tuberculosis in Bacille Calmette-Guérin-primed, HIV-infected adults boosted with an inactivated whole-cell mycobacterial vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Immunogenicity of a protective whole cell mycobacterial vaccine in HIV-infected adults: a phase III study in Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Therapeutic vaccines for tuberculosis--a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Granuloma encapsulation is a key factor for containing tuberculosis infection in minipigs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Double-blind, randomized, placebo-controlled Phase I Clinical Trial of the therapeutical antituberculous vaccine RUTI.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Safety, tolerability, and immunogenicity of the novel antituberculous vaccine RUTI: randomized, placebo-controlled phase II clinical trial in patients with latent tuberculosis infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Crystal Structure of Mycobacterium tuberculosis Zinc-dependent Metalloprotease-1 (Zmp1), a Metalloprotease Involved in Pathogenicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Functional characterization of the Mycobacterium tuberculosis zinc metallopeptidase Zmp1 and identification of potential substrates.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Mycobacterium tuberculosis prevents inflammasome activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Relief from Zmp1-mediated arrest of phagosome maturation is associated with facilitated presentation and enhanced immunogenicity of mycobacterial antigens.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Deletion of zmp1 improves Mycobacterium bovis BCG-mediated protection in a guinea pig model of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

BCG Δzmp1 vaccine induces enhanced antigen specific immune responses in cattle.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

BCG vaccination and leprosy protection: review of current evidence and status of BCG in leprosy control

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

In search of a new paradigm for protective immunity to TB

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

A small jab - a big effect: nonspecific immunomodulation by vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Longitudinal changes in CD4(+) T-cell memory responses induced by BCG vaccination of newborns

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCG.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Identifiers

10.1016/J.VACCINE.2015.03.056

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/25882170

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/25882170

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50564697&oldid=2070455722"